Orchid Pharma Ltd Nine Monthly Results

Gross Sales

684.45

602.27

456

381.43

330.5

Excise Duty

0

0

0

0

0

Net Sales

684.45

602.27

456

381.43

330.5

Other Operating Income

0

0

0

0

0

Other Income

23.58

17.86

17.7

67.65

3.94

Total Income

708.02

620.12

473.7

449.07

334.44

Total Expenditure

595.25

521.42

412.07

356.48

298.2

PBIDT

112.77

98.7

61.63

92.59

36.24

Interest

10.63

12.89

24.74

27.55

39.45

PBDT

102.14

85.81

36.89

65.04

-3.21

Depreciation

25.67

24.82

47.57

60.4

88.59

Minority Interest Before NP

0

0

0

0

0

Tax

-0.15

0

0

0

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

76.62

60.99

-10.68

4.64

-91.8

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

77.36

58.64

-12.82

4.64

-91.8

Extra-ordinary Items

0

0

0

60.39

0

Adjusted Profit After Extra-ordinary item

77.36

58.64

-12.82

-55.75

-91.8

EPS (Unit Curr.)

15.25

12.32

-3.14

1.13

-22.49

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

50.72

40.82

40.82

40.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.47

16.38

13.51

24.27

10.96

PBDTM(%)

14.92

14.24

8.08

17.05

-0.97

PATM(%)

11.19

10.12

-2.34

1.21

-27.77